all report title image

GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Artificial Intelligence (AI) In Pharmaceutical Market, By Deployment Mode (Cloud and On-Premise), By Offering (Hardware, Software, Services), By Technology (Natural Language Processing, Context-Aware Processing, Deep Learning, Querying Method, Other), By Drug Type (Large Molecules and Small Molecules), By Application (Drug Discovery, Clinical Trial, Research & Development, Drug Manufacturing and Supply Chain, Others), By End User (Pharmaceutical & Biotechnology Companies, Hospitals and Diagnostic Centers, Academic & Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jul 2024
  • Code : CMI7209
  • Pages :172
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Global Artificial Intelligence (AI) In Pharmaceutical Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • NVIDIA Corporation
  • IBM Corporation
  • Exscientia
  • Insilico Medicine
  • Atomwise, Inc.
  • Cloud Pharmaceuticals, Inc.
  • Cyclica Inc.
  • Envisagenics, Inc.
  • Numerate, Inc.
  • Schrödinger, Inc.
  • Standigm
  • Turbine.ai
  • BenevolentAI
  • Recursion Pharmaceuticals
  • Owkin, Inc.
  • XtalPi Inc.
  • Valo Health
  • Absci

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.